FDA issues new draft guidance to improve diversity in clinical trial design
Posted | May 6, 2022The US Food and Drug Administration (FDA) is recommending sponsors include a plan to enrol more participants from underrepresented racial and ethnic populations into clinical trials. Under the new guidance,…
